Marie Naigeon

Centre National de la Recherche Scientifique — France

Medicine · Health Sciences

14h-index1.1kcitations86works2.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(69), Immunotherapy and Immune Responses(37), CAR-T cell therapy research(21), Immune cells in cancer(13), Renal cell carcinoma treatment(10)

Publications86 total

Supplementary Data 1 from High Circulating IL-6/IL-8 Is Associated with Intratumoral Myeloid Contexture and Poor Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade
2025Open Access
Data from High Circulating IL-6/IL-8 Is Associated with Intratumoral Myeloid Contexture and Poor Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade
2025Open Access
Supplementary Data 1 from High Circulating IL-6/IL-8 Is Associated with Intratumoral Myeloid Contexture and Poor Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade
2025Open Access
1525P High myeloid clonality rate predicts resistance to immune checkpoint blockers in non-small cell lung cancer
Annals of Oncology·2025
High Circulating IL-6/IL-8 Is Associated with Intratumoral Myeloid Contexture and Poor Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade
Clinical Cancer Research·2025
Abstract 6042: Baseline serum level of IgG targeting annexin A2 is predictive of response to immunotherapy in patients with advanced NSCLC
Cancer Research·2025
Supplementary Data1 from Metabolic Tumor Volume Assessed by 18F FDG–PET CT Scan as a Predictive Biomarker for Immune Checkpoint Blockers in Advanced NSCLC and Its Biological Correlates
2025Open Access
Data from Metabolic Tumor Volume Assessed by 18F FDG–PET CT Scan as a Predictive Biomarker for Immune Checkpoint Blockers in Advanced NSCLC and Its Biological Correlates
2025Open Access
Expanded senescent CD8 T cells in IMID patients are associated with distinct inflammatory cytokines
Clinical & Experimental Immunology·2025Open Access
Validation of the Lung Immune Prognostic Index in patients with untreated advanced non-small cell lung cancer: Post hoc analysis of the IMpower 130, 131 and 150 trials
Lung Cancer·2024· 2 citedOpen Access
Metabolic Tumor Volume Assessed by 18F FDG–PET CT Scan as a Predictive Biomarker for Immune Checkpoint Blockers in Advanced NSCLC and Its Biological Correlates
Clinical Cancer Research·2024· 12 citedOpen Access
Circulating Proteins Associated with Anti-IL6 Receptor Therapeutic Resistance in the Sera of Patients with Severe COVID-19
Journal of Proteome Research·2024
P1.08B.02 Circulating T-Cell Immunosenescence in Patients with Unresectable Locally Advanced NSCLC: Preliminary Results of the SENLOAD Study
Journal of Thoracic Oncology·2024Open Access
Blood-based circulating biomarkers for prediction of immune-checkpoint inhibitors efficacy in renal cell carcinoma
Exploration of Targeted Anti-tumor Therapy·2024· 4 citedOpen Access
POS1322 IMID PATIENTS SHOW EXPANDED SENESCENT CD8 T-CELLS ASSOCIATED WITH LEVELS OF CIRCULATING INTERFERON GAMMA AND IL-6
Annals of the Rheumatic Diseases·2024
B cells and the coordination of immune checkpoint inhibitor response in patients with solid tumors
Journal for ImmunoTherapy of Cancer·2024· 29 citedOpen Access
Safety and efficacy of nivolumab in elderly patients with metastatic clear cell renal cell carcinoma: Analysis of the NIVOREN GETUG-AFU 26 study
European Journal of Cancer·2024· 2 cited
23P Circulating immune cells and activity of immune checkpoint inhibitors in metastatic renal cell carcinoma
Immuno-Oncology Technology·2023Open Access
184P Elevated baseline circulating IL-8 is associated with increased expression of the IMmotion myeloid gene signature (GS) in metastatic clear cell renal cell carcinoma (mRCC) patients (pts) treated with nivolumab (nivo) within the NIVOREN GETUG-AFU 26 study
Immuno-Oncology Technology·2023· 2 citedOpen Access
Human virome profiling identified CMV as the major viral driver of a high accumulation of senescent CD8 <sup>+</sup> T cells in patients with advanced NSCLC
Science Advances·2023· 32 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Nathalie Chaput(43), Benjamin Besse(28), Lydie Cassard(27), Lisa Boselli(25), Aude Desnoyer(25), Boris Duchemann(21), Jonathan Grivel(20), Laura Mezquita(20), David Planchard(20), Roberto Ferrara(19), Édouard Auclin(19), Aurélien Marabelle(19), Caroline Caramella(16), Lizza Hendriks(16), Jordi Remón(16), Laurence Albigès(14), Matthieu Texier(12), Sabina Sangaletti(12), Jean-Mehdi Jouniaux(12), Marina Chiara Garassino(11)